ENTITY
Medy Tox Inc

Medy Tox Inc (086900 KS)

52
Analysis
Health CareSouth Korea
Medy-Tox Inc. is a biopharmaceutical company. The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.
more
Refresh
27 May 2022 19:14

Beauty Farm Medical and Health Industry Pre-IPO: Near-Term Operating Environment Is Not Beautiful

BFM enjoys leadership positioning in a large and growing addressable market. However, investors can avoid this issue due to COVID-related...

Logo
590 Views
Share
bearishHugel Inc
20 Apr 2022 00:51

Korean Botox Players in Another Round of Patent Fights: Medytox (086900 KS) Sues Hugel (145020 KS)

Medytox has initiated a legal battle against Hugel, accusing Hugel of stealing its botulinum toxin strains and production methods. This may delay...

Logo
309 Views
Share
bearishBNC Korea
08 Apr 2022 18:33

BNC Korea (256840 KS): Late Mover in COVID Pill; 2021 Operating Loss and Russia Exposure Add to Woe

I am still bearish on the company as its partnered COVID-19 pill will be a late entrant in the market. Moreover, its huge dependence on Russia for...

Logo
433 Views
Share
bearishBNC Korea
29 Oct 2021 22:50

BNC Korea (256840 KS): Oral COVID-19 Treatment No More Remains a Catalyst

In-licensed oral COVID-19 treatment no longer remains a catalyst after competitor's encouraging clinical trial results. Other oral treatments are...

Logo
101 Views
Share
bearishHugel Inc
15 Aug 2021 05:44

The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?

The fight to acquire Hugel Inc (145020 KS) is now finally down to between the GS Group led consortium and the Goldman Sachs led consortium.

Logo
391 Views
Share
x